Fact CheckerSign in

NCT06961110Active, not recruiting

Evaluation of Molecular Hydrogen Supplementation to Enhance the Efficacy of Weight Loss Retreat in Overweight and Obese Adolescents

Evaluation of Molecular Hydrogen Supplementation to Enhance the Efficacy of Weight Loss Retreat in Overweight and Obese Adolescents. A Randomized, Double-blind, Parallel-group, Placebo-controlled Trial

Source: ClinicalTrials.gov · Last updated 2 Jun 2026

Brief summary (registry, in English)

This randomized controlled trial evaluates whether molecular hydrogen supplementation enhances the effectiveness of a 4-week weight loss retreat in overweight and obese adolescents. Outcome measures include: body composition, physical status, blood samples (insulin sensitivity, lipid profiles, markers of oxidative stress and inflammation) and autonomic nervous system function.

Status (registry)
Active, not recruiting
Study type
Interventional
Enrollment
60 (actual)
First submitted
29 Apr 2025
Start date
12 May 2025
Primary completion date
29 May 2026
Lead sponsor
Palacky University
Diseases
Obesity
NCT number
NCT06961110

What you commit to

  • Study type: Interventional
  • Participants enrolled: 60
  • From 12 May 2025 to the primary completion date, 29 May 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Cardio-respiratory disorders.
  • Musculoskeletal disorders.
  • Use of any medications regulating heart rhythm or the neurovegetative and hormonal system.

Other

  • High blood pressure.
  • Dyslipoproteinemia.

Who the study is looking for

  • Body mass index indicating overweight or obesity, as determined according to the World Health Organization's international percentile charts for children aged 5-19 years.
  • Presence of a regular menstrual cycle in female participants.
  • Signed informed consent from the legal representative.

Age in the registry: 11 years to 18 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Palacký University, Faculty of Physical Culture
Coordinator of this site? Confirm its status
OlomoucCzechiaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.